Vascular occlusion after dermal filler can lead to vision loss, and blunt tip microcannulas do not remove that risk. No injection tool does.
This guide explains how filler occludes a vessel, what a published review of 98 cases of vision change reports, where blunt tip cannulas fit, and where training on vascular complications comes in.
Can a Microcannula Prevent Blindness?
No. A larger cannula may lower the risk of vascular complications but does not make it zero.
The facial arterial system is a danger zone for filler injection, because intra-arterial injection can potentially lead to widespread necrosis and even blindness. Blindness can occur from injection into an artery near the orbit and requires rapid specialist intervention. Minimizing the risk of intra-arterial injection is therefore of paramount importance.
The tool is one part of that. The review cited below discusses both avoiding and treating blindness from fillers, and hands-on training covers the protocol. This page is general information for licensed practitioners and is not a clinical protocol.
How Filler Causes Vascular Occlusion
A vessel can become occluded in two ways: filler injected inside the vessel, or filler pressing on it from outside.
In the first, an artery is entered and filler is injected within the lumen (intraluminal). The filler travels down the vessel until it lodges, and it stops the flow of blood to the areas that depend on that supply. Smaller pieces can break off and travel to areas far from the injection site and into very small arterioles.
In the second, external compression, filler presses on the vessel from outside. This is plausible in areas of compartmentalization such as the nasal tip, where blood flow stops if the pressure within the compartment exceeds the pressure within an artery.
The worst cases of vascular occlusion end in blindness. A filler embolus travels through an anastomosis between the external and internal carotid systems. The filler backs up into the central retinal artery, which feeds the retina. Blood flow to the retina is blocked.
What the Published Case Review Reports
Beleznay et al., in a review of the world literature published in Dermatologic Surgery in 2015, identified 98 cases of vision changes from filler.
The review reports these figures:
- Sites: glabella 38.8%, nasal region 25.5%, nasolabial fold 13.3% and forehead 12.2%.
- Filler types: autologous fat 47.9% and hyaluronic acid 23.5%.
- Symptoms: the most common were immediate vision loss and pain.
- Outcomes: most cases of vision loss did not recover. Central nervous system complications were seen in 23.5% of cases.
- Treatment: no treatments were found to be consistently successful in treating blindness.
The full citation is in the Sources list below.
Where Blunt Tip Cannulas Fit
Blunt tip cannulas are an alternative to the sharp needle, and they are one option when you weigh placement and risk.
With a sharp needle, tip placement is considered very precise, and placing the tip on the periosteum is often thought to avoid intravascular injection for two reasons: very few arteries run over the periosteum, and a needle with an artery in its path is assumed to pass completely through it. The final placement of filler at this level cannot be guaranteed, however. Cannula techniques are sometimes regarded as less precise than needle techniques because cannulae are harder to maneuver to the periosteal level, but needle placement at that level is not guaranteed either.
Cannula use is still limited, for three reasons:
- Sourcing. Many injectors lack a reliable source of medical-grade microcannulas, which require exact specifications for manufacture and distribution.
- Experience. Cannula use differs from needle use in the force needed to push a blunt tip through tissue, the detailed knowledge needed to determine injection sites, and the different flow of material through a flexible shaft. These differences take practice and training to master.
- Procedures suited to needles. Some treatments still work better with a sharp tip needle, and Botox is an injectable not applied with microcannulas. An injector who is unsure how to proceed with a cannula should defer to a needle.
If you use cannulas, three sizes on our hub carry listed uses relevant to this discussion:
- 22 gauge 50 mm blunt tip microcannula: mid bore, listed for routine cheek, mid-face and jawline filler.
- 25G 50 mm microcannula: fine bore, listed for fine lines and superficial planes.
- 25G 38 mm microcannula: fine bore, listed for lips, fine lines and compact facial zones.
Each has a blunt, flexible, atraumatic tip in medical-grade stainless steel, comes 20 to a box, and is sterile and individually packed for use on one patient. Each comes packed with its own pilot (entry) needle. For lip work specifically, see choosing a cannula for lip filler.


